Cano Health, Inc. (NYSE:CANO) Receives Consensus Rating of "Reduce" from Analysts
Cano Health, Inc. (NYSE:CANO – Get Free Report) has received a consensus rating of “Reduce” from the nine brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation and eight have assigned a hold recommendation to the company. The average 1 year price objective among brokerages […]